Mirvetuximab [1453084-36-0]

TargetMol Chemicals

Mirvetuximab

9

1453084-36-0

Antibody

Research Use Only

Mirvetuximab

SDS-PAGE:95% SEC-HPLC:95%

Mirvetuximab (M9346A) is a novel folate receptor alpha (FRalpha) monoclonal antibody targeting anti-FOLR1 (folate receptor 1). Mirvetuximab soravtansine is often conjugated with platinum compounds or other compounds to form antibody-drug conjugates for the treatment of ovarian cancer and other FRalpha-positive cancers.

3 years

-20°C

12352203